Dr Brian Dang, PHARMD in Stanford, CA - Pharmacist

Dr Brian Dang, PHARMD is a Pharmacist - Critical Care based in Stanford, California. Dr Brian Dang is licensed to practice in California (license number 29535) and his current practice location is 500 Pasteur Drive Room J010, Stanford, California. He can be reached at his office (for appointments etc.) via phone at (650) 497-1718.

NPI number for Dr Brian Dang is 1588010235 and his current mailing address is 500 Pasteur Drive Room J010, Stanford, California. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1588010235.

Contact Information

	Dr Brian Dang, PHARMD
	500 Pasteur Drive Room J010, Stanford, CA 94305
	(650) 497-1718
	Not Available

Healthcare Provider's Profile

Full Name	Dr Brian Dang
Gender	Male
Speciality	Pharmacist - Critical Care
Location	500 Pasteur Drive Room J010, Stanford, California
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1588010235
Provider Enumeration Date: 05/12/2016
Last Update Date: 04/22/2020

Medical Identifiers

Medical identifiers for Dr Brian Dang such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1588010235	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1835C0205X	Pharmacist - Critical Care	29535 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Brian Dang is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Brian Dang, PHARMD 500 Pasteur Drive Room J010, Stanford, CA 94305 Ph: (650) 497-1718	Dr Brian Dang, PHARMD 500 Pasteur Drive Room J010, Stanford, CA 94305 Ph: (650) 497-1718

News Archive

Chemical used to make fireworks found in powdered baby milk

Scientists in the United States have found traces of a chemical used to make fireworks and rocket fuel in powdered baby milk.

Integrated health, education and water/sanitation programs can defeat disease and poverty

As governments prepare to gather at the United Nations General Assembly in New York on September 19 and 20, a new report published by a group of six influential aid agencies provides clear and compelling evidence that a combined approach to tackling poverty and disease-that brings together work on water and sanitation, health, education, and nutrition/food security-achieves better results for the world's poorest.

Merck announces significant price cuts on two of its AIDS drugs, Stocrin and Isentress

As more than 20,000 people from around the world gather this weekend for the start of the XVII International AIDS Conference in Mexico City, AIDS Healthcare Foundation (AHF) the US-based NGO which provides HIV/AIDS medical care and/or services to more than 79,000 individuals in 20 countries worldwide-including at four free treatment clinics in Mexico-commended Merck & Company (known as Merck, Sharp & Dohme in Mexico) over price cuts on two of its key AIDS drugs in Mexico which were announced yesterday before Sunday's opening of the AIDS conference.

Community Health Navigator Program for Houston's Burmese refugees may become a national model

The Physician Assistant Foundation (PAF), Baylor College of Medicine and other local partners today unveiled their unique approach to providing health care and social services to Burmese refugees in Houston, with hopes the program could become a model for meeting similar needs of refugees across the country.

Micromet announces presentation of updated results from MT103 Phase 2 trial in MRD positive ALL patients

Micromet, Inc. today announced the presentation of updated results from a Phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with minimal residual disease (MRD) positive acute lymphoblastic leukemia (ALL). An analysis of long-term efficacy data demonstrated that blinatumomab produced prolonged remissions in patients with ALL. As of November 2010, the hematologic disease free survival (DFS) was 60%, with a follow-up of up to 27.5 months.

Pharmacist in Stanford, CA

Kathi Salmon Lucas, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Pasteur Dr # H0301, Stanford, CA 94305 Phone: 650-725-5804
Sandy On, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Pasteur Dr, Rm H0301, M/c 5616, Stanford, CA 94305 Phone: 650-498-4387
Dr. William Thomas Moy, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Pasteur Dr, H0301, M/c 5616, Stanford, CA 94305 Phone: 650-725-5205
Dr. Christopher Jordan Diaz, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-724-3449
Ms. Ann Vongspanich, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-736-2789
Noah Chung Fang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-8363
Dr. Michael Gregory Blyumin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Pasteur Dr Rm H0301c, Stanford, CA 94305 Phone: 650-493-9973

Dr Brian Dang, PHARMD - Pharmacist in Stanford, CA